New immune therapy combo tested to fight tough pancreatic cancer
NCT ID NCT02451982
Summary
This study is testing a new combination of immune-based treatments for pancreatic cancer. It gives patients a cancer vaccine and a drug that helps the immune system fight cancer, both before and after surgery to remove the tumor. The main goal is to see if this approach is safe and can change the immune system's activity in and around the tumor to help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231-2410, United States
Conditions
Explore the condition pages connected to this study.